Skip to main content
Livermore
Livermore
ZHEN

Contineum Therapeutics, Inc.

CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001855175

In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Holders of 5% or more of CTNM

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Contineum Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CTNM
HolderLatest formStakeChangeFirst filedLatest filingFiling
Janus Henderson Group PLC13G7.90%2.45M sharesNewFeb 17, 20261 filingFeb 17, 2026SEC
Balyasny Asset Management LLC13G/A7.14%2.34M shares−0.26 ppfrom 7.40%Feb 17, 20263 filingsAug 14, 2026SEC
BlackRock, Inc.13G6.30%2.05M sharesNewJul 27, 20261 filingJul 27, 2026SEC
Franklin Resources Inc13G/A6.20%1.88M shares−1.50 ppfrom 7.70%Oct 31, 20244 filingsJan 29, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

22 Schedule 13D and 13G filings on Contineum Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CTNM
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20266:02 AM ETBalyasny Asset Management LLCand 4 others13G/A7.14%2.34M shares−0.26 ppfrom 7.40%Jun 30, 2026SEC
Jul 27, 20264:25 PM ETBlackRock, Inc.13G6.30%2.05M sharesNewJun 30, 2026SEC
Jul 17, 20265:10 PM ETMillennium Management LLCand 2 others13G/A2.80%931.7K shares−2.30 ppfrom 5.10%Below 5%Jun 30, 2026SEC
May 15, 20264:38 PM ETRa Capital Management, L.P.and 3 others13G/A4.00%1.30M shares−3.20 ppfrom 7.20%Below 5%Mar 31, 2026SEC
May 15, 20266:41 AM ETBalyasny Asset Management LLCand 4 others13G7.40%2.42M shares−0.20 ppfrom 7.60%Mar 31, 2026SEC
Apr 17, 20264:42 PM ETMillennium Management LLCand 2 others13G5.10%1.66M sharesNewApr 13, 2026SEC
Feb 17, 20264:23 PM ETRa Capital Management, L.P.and 3 others13G/A7.20%2.18M shares−2.70 ppfrom 9.90%Dec 31, 2025SEC
Feb 17, 202612:57 PM ETJanus Henderson Group PLC13G7.90%2.45M sharesNewDec 31, 2025SEC
Feb 17, 20266:28 AM ETBalyasny Asset Management LLCand 4 others13G7.60%2.31M sharesNewDec 31, 2025SEC
Jan 29, 202610:38 AM ETFranklin Resources Incand 3 others13G/A6.20%1.88M shares−1.50 ppfrom 7.70%Dec 31, 2025SEC
Nov 4, 202510:38 AM ETFranklin Resources Incand 3 others13G/A7.70%1.66M shares−1.20 ppfrom 8.90%Sep 30, 2025SEC
Aug 14, 20254:26 PM ETPerceptive Advisors LLCand 2 others13G/A3.20%699.5K shares−4.30 ppfrom 7.50%Below 5%Jun 30, 2025SEC
Aug 5, 202511:22 AM ETFranklin Resources Incand 3 others13G/A8.90%1.70M shares+1.30 ppfrom 7.60%Jun 30, 2025SEC
Jul 25, 20255:00 PM ETRa Capital Management, L.P.and 3 others13G9.90%2.12M sharesNewJul 18, 2025SEC
May 15, 20254:30 PM ETPerceptive Advisors LLCand 2 others13G/A7.50%1.44M shares+1.90 ppfrom 5.60%Mar 31, 2025SEC
Feb 14, 20254:15 PM ETPerceptive Advisors LLCand 2 others13G/A5.60%1.44M shares–Dec 31, 2024SEC
Feb 14, 202510:50 AM ETSectoral Asset Management Incand 1 other13G/A4.99%950.8K shares–Below 5%Dec 31, 2024SEC
Nov 14, 2024Sectoral Asset Management Inc13GOld format–New–SEC
Oct 31, 202412:46 PM ETFranklin Resources Incand 3 others13G7.60%1.45M sharesNewSep 30, 2024SEC
Apr 15, 2024Perceptive Advisors LLC13GOld format–New–SEC
Apr 15, 2024Suvretta Capital Management, LLC13GOld format–New–SEC
Apr 10, 20245:12 PM ETJohnson & Johnson13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Contineum Therapeutics, Inc. shares.

No Form 144 notices for Contineum Therapeutics, Inc. are on file.